Society of Urologic Oncology position statement: redefining the management of hormone-refractory prostate carcinoma.

@article{Chang2005SocietyOU,
  title={Society of Urologic Oncology position statement: redefining the management of hormone-refractory prostate carcinoma.},
  author={Sam S. Chang and M. Christina Benson and Steven C Campbell and J. F. Crook and Robert Dreicer and Christopher P Evans and Michelle C. Hall and Celestia S. Higano and William Kevin Kelly and Oliver A Sartor and Joseph Alexander Smith},
  journal={Cancer},
  year={2005},
  volume={103 1},
  pages={
          11-21
        }
}
Because patients with hormone-refractory prostate carcinoma are a very diverse group, management of these patients represents a unique challenge. Despite much research, to the authors' knowledge few studies published to date have provided definitive treatment answers. The Society of Urologic Oncology (SUO) convened a multidisciplinary panel of urologists, oncologists, and radiation oncologists to develop a treatment algorithm for patients with hormone-refractory prostate carcinoma. The… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-9 OF 9 CITATIONS

Similar Papers

Loading similar papers…